Epivir-HBV

lamivudine · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Epivir-HBV, covering 2011-01-31 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Lamivudine Therapy for Chronic Hepatitis B [Phase 4]